medigraphic.com

2003, Number 4

<< Back Next >>

Cir Cir 2003; 71 (4)

Duodenogastroesophageal reflux -and esophagitis- induced disease

Nina-Virreira CO, Arenas-Osuna J, Quiroga-Via H

Language: Spanish
References: 40
Page: 286-295
PDF size: 86.73 Kb.


ABSTRACT

Objective: Our objective was to determine the relationship between reflux of duodenogastric contents with different degrees of esophagitis, and its levels and activity, with regard to the severity of esophagitis-induced duodenogastroesophageal reflux disease (DGERD). Material and methods: Our study design was prospective, transversal, descriptive, observational, and open. We took samples of gastric and esophageal juices from patients with a diagnosis of gastroesophageal reflux disease (GERD) and esophagitis during the period from March to August 2002. Sample material was placed in black rubber-covered assay tubes to prevent bilirubin degradation. In our Unit’s central laboratory, these samples were centrifuged for 30 min, the dissolved material separated, and a reactive strip was introduced to measure the amount of bile pigment. Endoscopic study reports were provided by this Department on terminating the procedure. Univariate analysis was used to obtain results. Results: In 60% of cases, the esophageal liquid was positive for total bilirubin; 40% presented stage II esophagitis, 27% chronic esophagitis, and 27%, stage I esophagitis. Specific quantifications of total bilirubin at different stages of esophagitis demonstrated in stage II 50% with levels of 0.1-1, 33% with a level of 2-3, in cases of chronic esophagitis 75% with levels of 0.1-1, and with stage I esophagitis, 25% with levels of 2-3 mg/dl. Measurement of gastric pH showed 18 (69%) < 3 and esophageal pH of 20 (67%) > 4, with 10 (33%) referring occasional or asymptomatic dyspepsia. We determined presence of duodenal elements in esophagus by means of quantification of total bilirubin in 60% of patients, observing greatest frequency of stage II esophagitis. Low but continuous levels of duodenal, principally biliary, ele ments continued in patients with DGERD, producing greatest damage in esophageal mucosa.


REFERENCES

  1. Seymur IG. Tom S, Frank C, Josef E, et al. Principios de cirugía. Vol. I. 7th ed. 1999;23:1157-1259.

  2. Michael J, Seymur I, Harold E, et al. Operaciones abdominales. Vol. I. 10th ed. 1998;23:729-779.

  3. Ritter MD, Vanderpool MD, Westmoreland MD. Laparoscopic Nissen funduplication for gastroesophageal reflux disease. Am J Surg 1997;174:715-718.

  4. Vaezi PHD, Richter MD. Bile reflux in columnar-lined esophagus. Gatroenterol Clin 1997;26(3):565-582.

  5. Vaezi MF, Richter JE. Contribution of acid and duodenogastro-oesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997;41(3):297-302.

  6. Vaezi MF, Richter JE. Double reflux: double trouble. Gut 1999;44(5):590-592.

  7. Vaezi MF, Richter JE. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice. Hepatogastroenteroly 1999;46(25):40-47.

  8. Herzog D. Is alkaline gastroesophageal reflux an etiology for esophagitis? Z Gastroenterol 1997;35(12):1093-1100.

  9. Marshall REK, Anggiansah A, Owen WA, et al. The extent of duodenogastric reflux in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001;13(1):5-10.

  10. Marshall REK, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997;84(1):21-28.

  11. Bechi P, Cianchi F, Mazzanti R, et al. Reflux and pH; ‘alkaline’ components are not neutralized by gastric pH variations. Dis Esophagus 2000;13(1):51-55.

  12. Yamashita Y, Inoue H, Ohta K, et al. Manometric and hormonal changes after distal partial gastrectomy. Aliment Pharmacol Ther 2000;14 (Suppl 1):166-169.

  13. Manifold DK, Anggiansah A, Owen WJ. Effect of cholecystectomy on gastroesophageal and duodenogastric reflux. Am J Gastroenterol 2000;95(10):2746-2750.

  14. Wang W, Ji S, Wang H, et al. 24-Hour gastroesophageal double pH monitoring acid and alkaline gastroesophageal and duodenogastric refluxes in pediatric patients. Chin Med J (Engl) 1998;111(10):881-884.

  15. Byrne JP, Romagnoli R, Bechi P, et al. Duodenogastric reflux of bile in health: the normal range. Physiol Meas 1999;20(2):149-158.

  16. Sobrino FM, Domínguez MJ. Enfermedad por reflujo gastroesofágico: aspectos actuales etiopatogénicos y diagnósticos. Rev Esp Enferm Dig 2001;93:114-119.

  17. Eloubeidi MA, Provenzale D. Clinical and demographic predictors of Barrett’s esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 2001;33(4):306-309.

  18. Arango ML, Angel PA, Santacoloma AM, et al. Diagnóstico endoscópico vs diagnóstico histológico: correlación en la valoración de los pacientes con esofagitis por reflujo. Endoscopia 2000;28:234-242.

  19. Romagnoli C, Bechi S. Gastric symptoms and duodenogastric reflux in patients referred for gastroesophageal reflux symptoms and endoscopic esophagitis. Surgery 1999;125(5):480-486.

  20. Marshall REK, Anggiansah A, Owen W A, et al. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997;40(2):182-187.

  21. DiPalma JA. Management of severe gastroesophageal reflux disease. J Clin Gastroenterol 2001;32(1):19-26.

  22. Simic A, Pesko P. Significance of duodenogastric reflux in patients with erosive esophagitis. Acta Chir Iugosl 2000;47(3):67-72.

  23. Fisichella PM, Di Stefano A, Di Carlo I, et al. Difficulties in defining and diagnosing gastroesophageal reflux: practical implications in surgery. Ann Ital Chir 2000;71(5):559-563, Discussion 563-564.

  24. Menges M, Müller M, Zeitz M. Increased acid and bile reflux in Barrett’s esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001;96(2): 331-337.

  25. Nehra D, Howell P, Pye J K, et al. Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease. Br J Surg 1998;85(1):134-137.

  26. Nehra D, Howell P, Williams CP, et al. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999;44(5):598-602.

  27. Penagini R. Bile reflux and oesophagitis. Eur J Gastroenterol Hepatol 2001;13(1):1-3.

  28. D’Onofrio V, Bovero E, Iaquinto G. Characterization of acid and alkaline reflux in patients of Barrett’s esophagus. G.O.S.P.E. Operative Group for the Study of Esophageal Precancer. Dis Esophagus 1997;10(1):16-22, Discussion 22-23.

  29. Wetscher GJ, Schwelberger H, Unger A, et al. Reflux induced apoptosis of the esophageal mucosa is inhibited in Barrett’s epithelium. Am J Surg 1998;176:569-573.

  30. Pera M, Grande L, Gelabert M, et al. Epithelial cell hyperproliferation after biliopancreatic reflux into the esophagus of rats. Ann Thorac Surg 1998;65(3):779-786.

  31. Dixon MF, Neville PM, Mapstone MP, et al. Bile reflux gastritis and Barrett’s oesopahgus: further evidence of a role for duodenogastro-oesophageal reflux? Gut 2001;49(3):359-363.

  32. Sobrino FM, Domínguez MJ. Enfermedad por reflujo gastroesofágico: nuevas perspectivas terapéuticas. Rev Esp Enferm Dig 2001;93:248-252.

  33. Ferrando JC. Esófago de Barrett. sepd.org/fcjul99.htm

  34. Pera M. Cáncer de esófago. Aspectos fisiopatológicos. sepd.org/fcjul99.htm

  35. Lirón R, Parrilla P, Martínez LF, et al. Quantification of duodenogastric reflux in Barrett’s esophagus. Am J Gastroenterol 1997;92:32-36.

  36. Martínez de Haro L, Ortiz A, Parrilla P, et al. Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux. Ann Surg 2001;23(1):23-33.

  37. Kawiorski W, Herman RM, Legutko J. Pathogenesis and significance of gastroduodenal reflux. Przegl Lek 2001;58(1):38-44.

  38. Stein H J, Feith M, Siewert J R. Cancer of esophagogastric junction. Surg Oncol 2000;9(1):35-41.

  39. Endlicher E, Knuchel R, Messmann H. Surveillance of patients with Barrett’s esophagus. Z Gastroenterol 2001;39(8):593-600.

  40. Kawaura Y, Tatsuzawa Y, Wakabayashi T, et al. Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett’s esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model. J Gastroenterol 2001;36(9):595-600.




2020     |     www.medigraphic.com